Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05929937 · ClinicalTrials.gov registry record · Phase 4

No Opioids vs. Minimal Opioids Following Inguinal Hernia Repair

A Phase 4 study of Postoperative Pain and Inguinal Hernia, sponsored by Clayton Petro.

Active
Registry status
Phase 4
Development phase
904
Enrollment target
8
Study locations

NCT05929937 is a Phase 4 study of Postoperative Pain and Inguinal Hernia that is active but no longer recruiting, run by Clayton Petro. The registered enrollment target is 904 participants, above the 217-participant average among 63 other Postoperative Pain trials with a reported enrollment target (317% higher). The trial reports 8 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05929937, a Phase 4 study of Postoperative Pain and Inguinal Hernia, is active but no longer recruiting, sponsored by Clayton Petro.

ACTIVE NOT RECRUITING
Registry status
Phase 4
Development phase
904 participants
Enrollment target
8
Study locations

Study Summary

The investigators hypothesize that not prescribing opioids after uncomplicated, outpatient IHR will be non-inferior to prescribing opioids (5 tablets of Oxycodone, 5mg; or surgeon preference for intolerance) with respect to requests for opioid refills. Additionally, the investigators believe there will be no significant difference in postoperative readmission for pain quality of life at 30 days in either group.

Conditions Studied

Postoperative Pain Inguinal Hernia

Interventions

  • DRUG Opioids
  • OTHER No opioids

Study Locations (8)

Ohio

  • University Hospitals - Cleveland
  • Cleveland Clinic Center for Abdominal Core Health - Cleveland

California

  • MemorialCare - Fountain Valley

Michigan

  • Corewell Health - Royal Oak

South Carolina

  • Prisma Health - Greenville

Tennessee

  • University of Tennessee Medical Center - Knoxville

Wisconsin

  • Medical College of Wisconsin - Milwaukee

Ontario

  • North York General Hospital - Toronto

Trial Details

FieldValue
Enrollment Target 904 participants
Start Date 2023-07-10
Est. Completion 2027-07
Phase Phase 4

Sponsor

Clayton Petro

5 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05929937

The ClinicalTrials.gov registry entry for NCT05929937 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 904 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 217-participant average among 63 other Postoperative Pain trials with a reported enrollment target (317% higher). The listed sponsor is Clayton Petro, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Postoperative Pain appearing as the primary indexed condition, and to 2 interventions - of which Opioids is the first listed.

NCT05929937 reports 8 study locations spanning 7 distinct geographic areas - top geographies include Ohio, California, Michigan.

Frequently Asked Questions

What is clinical trial NCT05929937 about?

NCT05929937 is a clinical study titled "No Opioids vs. Minimal Opioids Following Inguinal Hernia Repair". The investigators hypothesize that not prescribing opioids after uncomplicated, outpatient IHR will be non-inferior to prescribing opioids (5 tablets of Oxycodone, 5mg; or surgeon preference for intolerance) with respect to requests for opioid refills. Additionally, the investigators believe there w...

What is the current status of trial NCT05929937?

This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 904 participants. The study started on 2023-07-10. Estimated completion is 2027-07.

What conditions does trial NCT05929937 study?

This clinical trial studies the following conditions: Postoperative Pain, Inguinal Hernia.

What interventions are being tested in trial NCT05929937?

The interventions under investigation include: Opioids (DRUG), No opioids (OTHER).

Who is sponsoring clinical trial NCT05929937?

This trial is sponsored by Clayton Petro, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05929937 being conducted?

This trial has 8 study locations across California, Michigan, Ohio, South Carolina, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Postoperative Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Postoperative Pain

All registered trials for this condition

Inguinal Hernia

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.